Diagonal Therapeutics News and Activities

Acquisition, funding and merger involving Diagonal Therapeutics.

• Diagonal Therapeutics has just announced a $125 Million fundraising (posted on January 16 2026).

View the org chart displaying its 13 main executives

Most searched biographies at Diagonal Therapeutics

• Alex Lugovskoy, Chief Executive Officer
• Clayton Knox, Director
• Barbara Fox, Director

Popular executive movements at Diagonal Therapeutics

• Jonathan Piazza has joined the company as Chief Financial Officer  (posted on May 8 2026).

Create your alert
to follow the executive moves at Diagonal Therapeutics.

Diagonal Therapeutics has 2,425 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Chemomab and Scipher Medicine have announced they will merge  (posted on July 13 2026)..
• Apnimed has filed its IPO. Its stock ticker will be APMD. (posted on July 13 2026).
• The new name of EG 427 is Cyllene Therapeutics. (posted on July 10 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by Diagonal Therapeutics

• Diagonal Therapeutics Expands Executive Leadership Team, Appoints Industry Veteran Jonathan Piazza as Chief Financial Officer | Diagonal Therapeutics

Social media about Diagonal Therapeutics

• Diagonal Therapeutics on Wikipedia, Google News & Yahoo Finance
• Diagonal Therapeutics on LinkedIn, X (Twitter) & YouTube